Laurent Garderet
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments 76
- Hematopoietic Stem Cell Transplantation 28
- Acute Myeloid Leukemia Research 10
- Oncology top 2%
- Cancer Treatment and Pharmacology 23
- Peptidase Inhibition and Analysis 15
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 13
- Immunology top 5%
- Molecular Biology top 5%
- Protein Degradation and Inhibitors 22
-
- Acute Lymphoblastic Leukemia research 9
- Co-authors
- Philippe MoreauThierry FaçonMichel AttalKarim BelhadjHervé Avet‐LoiseauBrigitte PegouriéÉliane GluckmanCyrille Hulin
- Cited by
- HematologyOncologyGenetics
- Journals
- The Lancet (1 paper)Journal of Clinical Oncology (8 papers)SHILAP Revista de lepidopterología (4 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
Laurent Garderet
121 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 97
- Hematology 2.6k
- Oncology 1.6k
- Genetics 429
- Immunology 637
- Molecular Biology 1.7k
Countries citing papers authored by Laurent Garderet
This map shows the geographic impact of Laurent Garderet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Garderet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Garderet more than expected).
Fields of papers citing papers by Laurent Garderet
This network shows the impact of papers produced by Laurent Garderet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Garderet. The network helps show where Laurent Garderet may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laurent Garderet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2021 | 3 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 9 | |
| 5 | 2020 | 4 | |
| 6 | 2019 | 12 | |
| 7 | 2018 | 20 | |
| 8 | 2016 | 49 | |
| 9 | 2016 | 5 | |
| 10 | 2014 | 72 | |
| 11 | 2012 | 16 | |
| 12 | 2012 | 6 | |
| 13 | Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma | 2010 | 4 |
| 14 | 2010 | 102 | |
| 15 | 2009 | 266 | |
| 16 | 2009 | 9 | |
| 17 | La génération in vitro de globules rouges humains : un modèle de recherche | 2007 | 1 |
| 18 | 2006 | 447 | |
| 19 | 2001 | 24 | |
| 20 | 2001 | 21 |
About Laurent Garderet
Laurent Garderet is a scholar working on Hematology, Oncology and Genetics, having authored 125 papers that have together received 3.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (76 papers), Hematopoietic Stem Cell Transplantation (28 papers), Cancer Treatment and Pharmacology (23 papers), Protein Degradation and Inhibitors (22 papers), Peptidase Inhibition and Analysis (15 papers), Chronic Lymphocytic Leukemia Research (13 papers), Acute Myeloid Leukemia Research (10 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Hematology (2.6k citations), Oncology (1.6k citations) and Genetics (429 citations). Laurent Garderet has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Philippe Moreau, Thierry Façon, Michel Attal, Karim Belhadj, Hervé Avet‐Loiseau, Brigitte Pegourié, Éliane Gluckman, Cyrille Hulin, Denis Caillot and Gérald Marit. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.